
Reset all filters
01 4Global Blood Therapeutics
02 2Pfizer Inc
Reset all filters
01 2Film Coated Tablet
02 1TABLET, FOR SUSPENSION;ORAL
03 3TABLET;ORAL
Reset all filters
01 3DISCN
02 1Suspensed
03 1Temporarily Withdrawn
04 1Blank
Reset all filters
01 4OXBRYTA
02 2Oxbryta
Reset all filters
01 1Spain
02 1Sweden
03 4USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : OXBRYTA
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-11-25
Application Number : 213137
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : OXBRYTA
Dosage Form : TABLET;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2022-10-14
Application Number : 213137
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : OXBRYTA
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2021-12-17
Application Number : 216157
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : OXBRYTA
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number : 216157
Regulatory Info :
Registration Country : USA
Regulatory Info : Temporarily Withdrawn
Registration Country : Sweden
Brand Name : Oxbryta
Dosage Form : Film Coated Tablet
Dosage Strength : 500mg
Packaging :
Approval Date : 14/02/2022
Application Number : 20201228000054
Regulatory Info : Temporarily Withdrawn
Registration Country : Sweden
Regulatory Info : Suspensed
Registration Country : Spain
Brand Name : Oxbryta
Dosage Form : Film Coated Tablet
Dosage Strength : 500MG
Packaging :
Approval Date : 2024-02-05
Application Number : 1211622001
Regulatory Info : Suspensed
Registration Country : Spain